154 related articles for article (PubMed ID: 35035680)
21. A Comprehensive Pan-Cancer Analysis of the Tumorigenic Role of Matrix Metallopeptidase 7 (MMP7) Across Human Cancers.
Meng N; Li Y; Jiang P; Bu X; Ding J; Wang Y; Zhou X; Yu F; Zhang Y; Zhang J; Xia L
Front Oncol; 2022; 12():916907. PubMed ID: 35785154
[TBL] [Abstract][Full Text] [Related]
22. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ
Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172
[TBL] [Abstract][Full Text] [Related]
23. Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets.
Zhang Y; Gao C; Cao F; Wu Y; Chen S; Han X; Mo J; Qiu Z; Fan W; Zhou P; Shen L
Front Oncol; 2021; 11():755341. PubMed ID: 34804946
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma.
Ma J; Chen X; Lin M; Wang Z; Wu Y; Li J
Cancer Cell Int; 2021 Jan; 21(1):65. PubMed ID: 33478508
[TBL] [Abstract][Full Text] [Related]
25. System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis.
Yi Y; Zhang Q; Shen Y; Gao Y; Fan X; Chen S; Ye X; Xu J
J Oncol; 2022; 2022():7945077. PubMed ID: 35154321
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive pan-cancer analysis reveals VSIR as a candidate immunologic, diagnostic, and prognostic biomarker.
Pan J; Mahsud I; Ul Haq M; Khan S; Alhomrani M; Alamri AS; Alghamdi SA; ALSuhaymi N; Baothman BK; Almaghrabi S; Ullah S; Jamil M
Am J Transl Res; 2024; 16(5):1630-1642. PubMed ID: 38883368
[TBL] [Abstract][Full Text] [Related]
27. Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancers.
Tang X; Sui X; Liu Y
Heliyon; 2023 Jan; 9(1):e12873. PubMed ID: 36685446
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers.
Zeng T; Li B; Shu X; Pang J; Wang H; Cai X; Liao Y; Xiao X; Chong Y; Gong J; Li X
Front Oncol; 2023; 13():1183474. PubMed ID: 37601657
[TBL] [Abstract][Full Text] [Related]
29. A pan-cancer analysis of the role of
Ding G; Ma T; Zhang K; Chen G; Shen J; Zhang S; Li K; Zhao C; Wang F; Sun J; Wang J
Biotechnol Genet Eng Rev; 2023 Mar; ():1-16. PubMed ID: 36971139
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Pan-Cancer Analysis Confirmed That ATG5 Promoted the Maintenance of Tumor Metabolism and the Occurrence of Tumor Immune Escape.
Xu C; Zang Y; Zhao Y; Cui W; Zhang H; Zhu Y; Xu M
Front Oncol; 2021; 11():652211. PubMed ID: 33842365
[TBL] [Abstract][Full Text] [Related]
31. An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (MSH6) in human tumors.
Zhan H; Mo F; Xu Q; Wang S; Zhang B; Liu X; Dai M; Liu H
Aging (Albany NY); 2021 Dec; 13(23):25271-25290. PubMed ID: 34941572
[TBL] [Abstract][Full Text] [Related]
32. Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.
Fu J; Song B; Du J; Liu S; He J; Xiao T; Zhou B; Li D; Liu X; He T; Cheng J; Fu J
Mol Biol Rep; 2023 Mar; 50(3):2269-2281. PubMed ID: 36574092
[TBL] [Abstract][Full Text] [Related]
33. Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.
Liu JN; Kong XS; Huang T; Wang R; Li W; Chen QF
Front Immunol; 2020; 11():2048. PubMed ID: 33072070
[TBL] [Abstract][Full Text] [Related]
34. Immune modulation and prognostic significance of MCM10 in pan-cancer: a comprehensive analysis.
Abdel-Maksoud MA; Iqbal K; Gull S; Kumar SK; Mastoor M; Almutairi SM; Almanaa TN; Alfuraydi AA; Mubarak A; Kotob MH; Jamil M; Zaky MY
Am J Transl Res; 2023; 15(11):6451-6463. PubMed ID: 38074804
[TBL] [Abstract][Full Text] [Related]
35. Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.
Xu Y; Xu WH; Shi SN; Yang XL; Ren YR; Zhuang XY; Qu YY; Zhang HL; Zhang XF
J Cancer; 2020; 11(20):6101-6113. PubMed ID: 32922550
[No Abstract] [Full Text] [Related]
36. Pan-Cancer Transcriptome and Immune Infiltration Analyses Reveal the Oncogenic Role of Far Upstream Element-Binding Protein 1 (FUBP1).
Wang H; Zhang R; Li E; Yan R; Ma B; Ma Q
Front Mol Biosci; 2022; 9():794715. PubMed ID: 35274005
[TBL] [Abstract][Full Text] [Related]
37. Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2.
Xu Q; Kong N; Zhao Y; Wu Q; Wang X; Xun X; Gao P
Front Genet; 2022; 13():864655. PubMed ID: 35586565
[TBL] [Abstract][Full Text] [Related]
38. The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
Ball MW; Gorin MA; Drake CG; Hammers HJ; Allaf ME
Eur Urol Focus; 2017 Dec; 3(6):584-589. PubMed ID: 28753846
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers.
Lan A; Ren C; Wang X; Tong G; Yang G
BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293
[TBL] [Abstract][Full Text] [Related]
40. Can CpG methylation serve as surrogate markers for immune infiltration in cancer?
Bacolod MD; Barany F; Fisher PB
Adv Cancer Res; 2019; 143():351-384. PubMed ID: 31202362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
